Safety of direct oral anticoagulants versus traditional anticoagulants in venous thromboembolism

Michela Giustozzi; Laura Franco; Maria Cristina Vedovati; Cecilia Becattini; Giancarlo Agnelli

doi:10.1007/s11239-019-01878-x

Related publications

Article2019

Efficacy and Safety of Direct Oral Anticoagulants for Risk of Cancer-Associated Venous Thromboembolism

Jie Zeng, Xuhui Zhang, Professor Gregory Lip, Xiaochen Shu, Lehana Thabane, Junzhang Tian, Guowei Li

Article2013

New oral anticoagulants for the treatment of venous thromboembolism

Giancarlo Agnelli, Cecilia Becattini, Laura Franco

Article2020

Direct Oral Anticoagulants for the Treatment of Acute Venous Thromboembolism Associated with Cancer: A Systematic Review and Meta-Analysis

Michela Giustozzi, Giancarlo Agnelli, Jorge del Toro‐Cervera, Frederikus A. Klok, Rachel Rosovsky, Anne‐Céline Martin, Joerg Herold, Inna Tzoran, Sebastian Szmit, Laurent Bertoletti, Cecilia Becattini, Menno V. Huisman

Article2022

Cost-effectiveness of direct oral anticoagulants compared to low-molecular-weight-heparins for treatment of cancer associated venous thromboembolism in Spain

Andrés J. Muñoz Martín, Enrique Gallardo, Giancarlo Agnelli, Carlos Crespo, Monica Forghani, Daniel Arumí, Susana Fernández de Cabo, Javier Soto

Article2022

Efficacy and Safety Considerations With Dose-Reduced Direct Oral Anticoagulants

Behnood Bikdeli, Farbod Zahedi Tajrishi, Parham Sadeghipour, Azita H. Talasaz, John Fanikos, Giuseppe Lippi, Deborah Siegal, John W. Eikelboom, Manuel Monréal, David Jiménez, Jean M. Connors, Walter Ageno, Geoffrey D. Barnes, Gregory Piazza, Dominick J. Angiolillo, Sahil A. Parikh, Ajay J. Kirtane, Renato D. Lópes, Deepak L. Bhatt, Jeffrey I. Weitz, Roxana Mehran, Harlan M. Krumholz, Samuel Z. Goldhaber, Professor Gregory Lip